FALBERG KATHRYN E bought RCUS
June 11, 2026 · Form 4 insider transaction
FALBERG KATHRYN E bought 5,700 shares of Arcus Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,700
Price
$0.00
Total value
N/A
InsiderFALBERG KATHRYN E
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 12, 2026
Shares owned after44,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.